Sarcopenia clinical trials at UCSF

1 in progress, 0 open to eligible people

Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and Sarcopenia
Sorry, in progress, not accepting new patients
This is a randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of LPCN 1148 in men with cirrhosis of the liver and sarcopenia.
San Francisco, California and other locations

Last updated: December 2022